| Line Item | 2025-11-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $141.8M | +9.4% | -0.8% |
| Cost of Revenue | $31.9M | -3.3% | +2.9% |
| Gross Profit | $109.9M | +13.8% | -1.9% |
| R&D Expense | $29.6M | +15.6% | +9.6% |
| SG&A Expense | $36.1M | +14.6% | -5.0% |
| Operating Income | $11.9M | +3.5% | -37.4% |
| Interest Expense | $1.5M | +0.0% | +50.0% |
| Pre-tax Income | $14.8M | +10.4% | -22.1% |
| Income Tax | $1.1M | +1000.0% | -84.3% |
| Net Income | $13.7M | +3.0% | +224.5% |
| EPS (Basic) | $0.02 | +0.0% | +200.0% |
| EPS (Diluted) | $0.02 | +0.0% | +200.0% |
| Line Item | 2025-11-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $270.3M | -2.2% | +43.0% |
| Short-term Investments | $33.9M | +140.4% | +9.4% |
| Accounts Receivable | $149.5M | +19.6% | -7.1% |
| Current Assets | $543.2M | +7.1% | +19.4% |
| Total Assets | $1.22B | +2.9% | -6.9% |
| Current Liabilities | $253.3M |
| Line Item | 2025-11-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $4.2M | — | — |
| Capital Expenditures | $2.6M | — | — |
| Investing Cash Flow | $30.8M | — | — |
| Financing Cash Flow | -$31.5M | — | — |
| Free Cash Flow | $1.6M | — | — |
| -23.7% |
| Long-term Debt | $196.2M | +0.2% | — |
| Total Liabilities | $477.3M | +4.0% | -18.3% |
| Stockholders' Equity | $741.1M | +2.2% | +2.2% |